CME Group (CME) director awarded 645 fully vested Class A shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Lucas Deborah J reported acquisition or exercise transactions in this Form 4 filing.
CME Group Inc. director Deborah J. Lucas received an equity award of Class A common stock. She was granted 645 fully vested shares at a price of $225 per share as part of CME Group’s annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. Following this grant, she directly holds 4,533 Class A shares. This is a compensation-related stock award, not an open-market purchase.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Lucas Deborah J
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock Class A | 645 | $225.00 | $145K |
Holdings After Transaction:
Common Stock Class A — 4,533 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Shares granted: 645 shares
Grant price: $225 per share
Post-transaction holdings: 4,533 shares
3 metrics
Shares granted
645 shares
Class A Common Stock grant to director
Grant price
$225 per share
Reported value for granted shares
Post-transaction holdings
4,533 shares
Direct Class A holdings after grant
Key Terms
fully vested, annual equity compensation program, non-employee directors, CME Group Director Stock Plan, +1 more
5 terms
fully vested financial
"Represents a grant of fully vested shares of Class A Common Stock"
annual equity compensation program financial
"issued to the Reporting Person as part of the Issuer's annual equity compensation program"
non-employee directors financial
"equity compensation program for non-employee directors under the CME Group Director Stock Plan"
Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.
CME Group Director Stock Plan financial
"for non-employee directors under the CME Group Director Stock Plan"
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
What insider transaction did CME (CME) director Deborah J. Lucas report?
Deborah J. Lucas reported receiving a grant of 645 fully vested CME Group Class A common shares at $225 per share as part of the company’s annual equity compensation program for non-employee directors.
Was the CME (CME) Lucas transaction a market purchase or a stock grant?
The transaction was a stock grant, not a market purchase. Lucas received 645 fully vested Class A shares as compensation under the CME Group Director Stock Plan for non-employee directors.